Garona, J., Pifano, M., Pastrian, M. B., Gómez, D. E., Ripoll, G. V., & Alonso, D. F. (2016). Addition of vasopressin synthetic analogue [V<sup>4</sup>Q<sup>5</sup>]dDAVP to standard chemotherapy enhances tumour growth inhibition and impairs metastatic spread in aggressive breast tumour models. Web
Citación estilo ChicagoGarona, Juan, Marina Pifano, María Belén Pastrian, Daniel Eduardo Gómez, Giselle Vanina Ripoll, and Daniel Fernando Alonso. Addition of Vasopressin Synthetic Analogue [V<sup>4</sup>Q<sup>5</sup>]dDAVP to Standard Chemotherapy Enhances Tumour Growth Inhibition and Impairs Metastatic Spread in Aggressive Breast Tumour Models. 2016.
Cita MLAGarona, Juan, et al. Addition of Vasopressin Synthetic Analogue [V<sup>4</sup>Q<sup>5</sup>]dDAVP to Standard Chemotherapy Enhances Tumour Growth Inhibition and Impairs Metastatic Spread in Aggressive Breast Tumour Models. 2016.